These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6215739

  • 1. In vivo platelet release in myeloproliferative disorders.
    Ireland H, Lane DA, Wolff S, Foadi M.
    Thromb Haemost; 1982 Aug 24; 48(1):41-5. PubMed ID: 6215739
    [Abstract] [Full Text] [Related]

  • 2. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P, Cortelazzo S, Bassan R, Barbui T.
    Thromb Haemost; 1982 Oct 29; 48(2):125-6. PubMed ID: 6184841
    [Abstract] [Full Text] [Related]

  • 3. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E.
    Ann Acad Med Stetin; 1998 Oct 29; 44():137-54. PubMed ID: 9857536
    [Abstract] [Full Text] [Related]

  • 4. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K, Sekiguchi E, Takatani O.
    Thromb Haemost; 1984 Dec 29; 52(3):292-6. PubMed ID: 6531753
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
    Wehmeier A, Fricke S, Scharf RE, Schneider W.
    Eur J Haematol; 1990 Oct 29; 45(4):191-7. PubMed ID: 2146144
    [Abstract] [Full Text] [Related]

  • 6. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML, Perry DW, Packham MA, Gemmell CH, Yeo EL, Kinlough-Rathbone RL.
    Am J Hematol; 1996 Aug 29; 52(4):288-94. PubMed ID: 8701947
    [Abstract] [Full Text] [Related]

  • 7. Platelet activation during steady state sickle cell disease.
    Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, Kakkar VV.
    J Med; 1983 Aug 29; 14(1):17-36. PubMed ID: 6224876
    [Abstract] [Full Text] [Related]

  • 8. Platelet function in sickle cell disease during steady state.
    Triadou P, Fonty E, Ambrosio AS, Cottat MC, Girot R, Cornu P.
    Nouv Rev Fr Hematol (1978); 1990 Aug 29; 32(2):137-42. PubMed ID: 2143013
    [Abstract] [Full Text] [Related]

  • 9. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H.
    Clin Nephrol; 1982 Jan 29; 17(1):24-30. PubMed ID: 6459902
    [Abstract] [Full Text] [Related]

  • 10. Platelet function studies in myeloproliferative disorders.
    Pfliegler G, Boda Z, Udvardy M, Kiss A, Telek B, Pecze K, Nagy P, Rak K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Jan 29; 113(5):655-62. PubMed ID: 2435631
    [Abstract] [Full Text] [Related]

  • 11. Platelet activation in myeloproliferative disorders.
    Cortelazzo S, Viero P, Barbui T.
    Thromb Haemost; 1981 Jun 30; 45(3):211-3. PubMed ID: 6169172
    [Abstract] [Full Text] [Related]

  • 12. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J.
    Thromb Haemost; 1984 Oct 31; 52(2):183-7. PubMed ID: 6084323
    [Abstract] [Full Text] [Related]

  • 13. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA.
    J Lab Clin Med; 1984 Jun 31; 103(6):894-904. PubMed ID: 6233383
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F, Randi ML, Casonato A, Dal Bo Zanon R, Bonvicini P, Girolami A.
    Acta Haematol; 1984 Jun 31; 71(1):32-8. PubMed ID: 6197855
    [Abstract] [Full Text] [Related]

  • 15. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C, Ciferri S, Mencarelli S, Mezzasoma AM, Momi S, Orlacchio A, Gresele P.
    Platelets; 2006 Feb 31; 17(1):20-9. PubMed ID: 16308183
    [Abstract] [Full Text] [Related]

  • 16. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
    Douglas JT, Shah M, Lowe GD, Belch JJ, Forbes CD, Prentice CR.
    Thromb Haemost; 1982 Feb 26; 47(1):54-5. PubMed ID: 6176042
    [Abstract] [Full Text] [Related]

  • 17. Increased platelet aggregation following splenectomy in patients with myeloproliferative disease.
    Aviram M, Carter A, Tatarsky I, Levy Y, Brook JG.
    Isr J Med Sci; 1985 May 26; 21(5):415-7. PubMed ID: 4019124
    [Abstract] [Full Text] [Related]

  • 18. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P, Cortelazzo S, Barbui T.
    Thromb Haemost; 1984 Jul 29; 51(3):411. PubMed ID: 6208631
    [No Abstract] [Full Text] [Related]

  • 19. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
    Kyrle PA, Westwick J, Scully MF, Kakkar VV, Lewis GP.
    Thromb Haemost; 1987 Feb 03; 57(1):62-6. PubMed ID: 2954260
    [Abstract] [Full Text] [Related]

  • 20. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M, Marchetti M, Russo L, Tartari CJ, Leuzzi A, Finazzi G, Rambaldi A, ten Cate H, Falanga A.
    Thromb Res; 2013 Jul 03; 132(1):88-93. PubMed ID: 23735588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.